Search research articles
Contact Us
Filters
Showing results (121-130 of 279) with videos related to
Page
of 28
Sort By:
Human Molecular Genetics
|
July 24, 2012
Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease
Carlos Cruchaga, John S K Kauwe, Petra Nowotny, et al.
JAMA Neurology
|
January 8, 2019
Assessment of Racial Disparities in Biomarkers for Alzheimer Disease
John C Morris, Suzanne E Schindler, Lena M McCue, et al.
BMJ Open
|
September 16, 2021
Falls: a marker of preclinical Alzheimer disease: a cohort study protocol
Rebecca M Bollinger, Audrey Keleman, Regina Thompson, et al.
Molecular Neurodegeneration
|
April 14, 2007
Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms
Suzanne E Wahrle, Aarti R Shah, Anne M Fagan, et al.
Neuroimage
|
December 20, 2016
In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging
Yue Zhao, Marcus E Raichle, Jie Wen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 13, 2018
Driving cessation over a 24-year period: Dementia severity and cerebrospinal fluid biomarkers
Sarah H Stout, Ganesh M Babulal, Chunyu Ma, et al.
Journal of Alzheimer'S Disease : JAD
|
December 13, 2021
Quantitative Gradient Echo MRI Identifies Dark Matter as a New Imaging Biomarker of Neurodegeneration that Precedes Tisssue Atrophy in Early Alzheimer's Disease
Satya V V N Kothapalli, Tammie L Benzinger, Andrew J Aschenbrenner, et al.
Alzheimer'S Research & Therapy
|
September 19, 2015
Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort
Maartje I Kester, Charlotte E Teunissen, Courtney Sutphen, et al.
Brain : a Journal of Neurology
|
September 14, 2017
Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levels
Yo-El S Ju, Sharon J Ooms, Courtney Sutphen, et al.
Neurology
|
April 12, 2013
Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later
Catherine M Roe, Anne M Fagan, Elizabeth A Grant, et al.
Page
of 28
Search research articles
Search
Showing results (121-130 of 279) with videos related to
Sort By:
Page
of 28
Human Molecular Genetics
|
July 24, 2012
Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease
Carlos Cruchaga, John S K Kauwe, Petra Nowotny, et al.
JAMA Neurology
|
January 8, 2019
Assessment of Racial Disparities in Biomarkers for Alzheimer Disease
John C Morris, Suzanne E Schindler, Lena M McCue, et al.
BMJ Open
|
September 16, 2021
Falls: a marker of preclinical Alzheimer disease: a cohort study protocol
Rebecca M Bollinger, Audrey Keleman, Regina Thompson, et al.
Molecular Neurodegeneration
|
April 14, 2007
Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms
Suzanne E Wahrle, Aarti R Shah, Anne M Fagan, et al.
Neuroimage
|
December 20, 2016
In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging
Yue Zhao, Marcus E Raichle, Jie Wen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 13, 2018
Driving cessation over a 24-year period: Dementia severity and cerebrospinal fluid biomarkers
Sarah H Stout, Ganesh M Babulal, Chunyu Ma, et al.
Journal of Alzheimer'S Disease : JAD
|
December 13, 2021
Quantitative Gradient Echo MRI Identifies Dark Matter as a New Imaging Biomarker of Neurodegeneration that Precedes Tisssue Atrophy in Early Alzheimer's Disease
Satya V V N Kothapalli, Tammie L Benzinger, Andrew J Aschenbrenner, et al.
Alzheimer'S Research & Therapy
|
September 19, 2015
Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort
Maartje I Kester, Charlotte E Teunissen, Courtney Sutphen, et al.
Brain : a Journal of Neurology
|
September 14, 2017
Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levels
Yo-El S Ju, Sharon J Ooms, Courtney Sutphen, et al.
Neurology
|
April 12, 2013
Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later
Catherine M Roe, Anne M Fagan, Elizabeth A Grant, et al.
Page
of 28